Vascular Risk Factors and Diabetic Neuropathy
Solomon Tesfaye(Sheffield Teaching Hospitals NHS Foundation Trust), John Fuller(The Royal Free Hospital), Daniel R. Witte(Steno Diabetes Centers), Nish Chaturvedi(Imperial College London), Simon E.M Eaton(Royal Hallamshire Hospital), Christos Manes(Papageorgiou General Hospital), John D. Ward(Royal Hallamshire Hospital), C Ionescu-Tîrgovişte
Cited by 1,279
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743